Literature DB >> 20212321

Multiplicity-calibrated Bayesian hypothesis tests.

Mengye Guo1, Daniel F Heitjan.   

Abstract

When testing multiple hypotheses simultaneously, there is a need to adjust the levels of the individual tests to effect control of the family-wise error rate (FWER). Standard frequentist adjustments control the error rate but are typically both conservative and oblivious to prior information. We propose a Bayesian testing approach-multiplicity-calibrated Bayesian hypothesis testing-that sets individual critical values to reflect prior information while controlling the FWER via the Bonferroni inequality. If the prior information is specified correctly, in the sense that those null hypotheses considered most likely to be false in fact are false, the power of our method is substantially greater than that of standard frequentist approaches. We illustrate our method using data from a pharmacogenetic trial and a preclinical cancer study. We demonstrate its error rate control and power advantage by simulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212321      PMCID: PMC2912702          DOI: 10.1093/biostatistics/kxq012

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  5 in total

1.  Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.

Authors:  Caryn Lerman; Christopher Jepson; E Paul Wileyto; Leonard H Epstein; Margaret Rukstalis; Freda Patterson; Vyga Kaufmann; Stephanie Restine; Larry Hawk; Ray Niaura; Wade Berrettini
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

2.  A Bayesian determination of threshold for identifying differentially expressed genes in microarray experiments.

Authors:  Jie Chen; Sanat K Sarkar
Journal:  Stat Med       Date:  2006-09-30       Impact factor: 2.373

3.  Clinical trials and statistical verdicts: probable grounds for appeal.

Authors:  G A Diamond; J S Forrester
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

4.  Identification of pharmacogenetic markers in smoking cessation therapy.

Authors:  Daniel F Heitjan; Mengye Guo; Riju Ray; E Paul Wileyto; Leonard H Epstein; Caryn Lerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

5.  Synchronization of breast cancer cell proliferation in vivo by combined hormonal and polyamine manipulation.

Authors:  A Manni; S Khin; N Biser; H English; B Badger; J Martel; L Demers
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

  5 in total
  2 in total

1.  Two-stage genome-wide search for epistasis with implementation to Recombinant Inbred Lines (RIL) populations.

Authors:  Pavel Goldstein; Abraham B Korol; Anat Reiner-Benaim
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

2.  Bayesian model averaging for nonparametric discontinuity design.

Authors:  Max Hinne; David Leeftink; Marcel A J van Gerven; Luca Ambrogioni
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.